JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 36 No. 11 2001-2005
© 1995 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, J. A.
Right arrow Articles by McCandless, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, J. A.
Right arrow Articles by McCandless, B. K.

Preventing Patient Motion during Tomographic Myocardial Perfusion Imaging

Jeffrey A. Cooper and Brian K. McCandless

Departments of Radiology, Pediatrics and Medicine, The Albany Medical College, Albany, New York

Correspondence: For correspondence or reprints contact: Jeffrey A. Cooper, MD, Nuclear Medicine, A-72, 47 New Scotland Ave, Albany Medical Center, Albany, NY, 12208.

ABSTRACT

We evaluated whether use of a device that positions and supports the upper extremities and back during tomographic myocardial perfusion imaging reduces the incidence and severity of patient motion and patient motion artifact. Methods: We enrolled 190 patients referred for stress/redistribution myocardial perfusion imaging. All patients were imaged once with the patient support device (PSD) and once without it. Patients were randomly assigned to use the PSD either during poststress or redistribution imaging. The presence and severity of patient motion was determined by visual inspection and quantitative motion detection. The presence of reconstruction artifact due to motion was detected visually and confirmed by motion correction. Results: Use of the PSD reduced the incidence of motion from 38% ± 3.7% to 26% ± 3.3% (p < 0.05) and reduced the amount of motion by 5.3 ± 2.2 mm (p < 0.05). Patients who did move, moved less when using the PSD by both visual (p < 0.02) and quantitative criteria (p < 0.05). Use of the PSD reduced the incidence of reconstruction artifacts to one third of control (p < 0.05). Conclusion: The use of this positioning and support device during tomographic myocardial perfusion imaging reduces the incidence and severity of patient motion and motion artifact.

Key Words: single-photon emission computed tomography • thallium-201 • patient motion







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1995 by the Society of Nuclear Medicine.